The Contaminated Blood case was set in the time of former Prime Minister Laurent Fabius, in which blood contaminated with dangerous viruses was distributed in France. In addition, the Mario France Institute produced blood coagulation factors contaminated with HIV and hepatitis and exports them to some countries such as West Germany, Italy, Argentina, Saudi Arabia, Iraq, Iran, etc. This factor is used to help coagulate the blood of many hemophiliacs and hospitalized patients, and because of the negligence of the French Institute, a certain number of hemophiliac patients were infected with HIV or hepatitis C as a result of a blood transfusion in these countries.
It’s just that the contaminated blood was distributed by the administration of Fabius for 6 months, but its problems for consumers have persisted for years and remain until now. French hemophilia organizations of the time state that due to the negligence of the administration of Fabius, almost 8,000 people were infected with the AIDS virus in France. The situation was much worse for the hepatitis virus. Following this blood transfusion, 400,000 French people were infected with the virus, among the transfused patients 4,000 people were hemophiliacs. The situation of hemophilia patients who had to endure the pain and problems of two other dangerous diseases like AIDS or hepatitis was much worse than the others. Considering that importing countries were more likely to receive special purpose blood products; This problem has become much more serious for hemophiliacs in these countries and has caused many victims.
In general, The Contaminated Blood case, by the number and quality of the victims and the intensity of the institutional crisis, seized the French with dread and generated a serious and deep public health crisis from the end of the 1970s to 1985. Due to the lack of necessary research on the AIDS epidemic, the lack of adequate screening, and adequate precautionary measures to avoid contamination, a large number of hemophiliacs have been infected by blood transfusion with the AIDS virus and ‘hepatitis. Due to the lack of necessary research on the AIDS epidemic, the lack of adequate screening, and adequate precautionary measures to avoid contamination, a large number of hemophiliacs have been infected by blood transfusion with the AIDS virus and ‘hepatitis. The victims of this contaminated blood were the inhabitants of many countries, including Germany, Italy, Argentina, Portugal, Saudi Arabia, Iran, France, Canada, Ireland, Great -Britain, Iraq, Greece, etc. It is estimated that in Canada, about 33,000 people, in the United States, between 6,000 and 10,000 citizens, and in Iran, 193 Iranians were infected with hepatitis C and AIDS-contaminated blood.
At that time, it was hoped that thanks to concentrate technology hemophilia patients would be improved. During the 1970s and 1980s, blood concentrates were collected in countries where, in some cases, ordinary people were paid to donate blood. This caused many people to donate blood in order to receive money whose blood was not suitable for transfusion. In the case of France, there was no payment for blood donation, but it turned out that some drug addicts in Paris were donating blood for sandwiches and free coffee. The main problem was that in blood concentrates, if a donor was infected with a blood-borne disease (hepatitis before the 1980s), he could contaminate all concentrates from a mixed blood group.
On the other hand, the AIDS virus was unknown until the early 1980s, and there was no evidence that it could be transmitted through blood concentrate. After it was learned that AIDS could be transmitted through these samples of blood, no proper screening was done to control donor blood and there was no method to detect and diagnose infections transmitted through contaminated blood. Competition among manufacturing companies for faster and larger production is also cited as one of the negative reasons for this.
At that time (the 1980s), the Mario Institute in France delivered blood coagulation factors for use by hemophiliacs in addition to France to ten countries including Germany, Italy, Argentina, Saudi Arabia, Iraq, Iran, and Greece. Sometime later, France announced to the blood recipient countries that the blood carried the HIV/AIDS virus. Some countries returned the blood, some threw it away, but in some cases, like Iran, before the implementation of blood testing, the National Blood Transfusion Center of Iran injected the contaminated blood to patients. These products have been distributed to 976 hemophilia patients in Iran, and 193 of them were infected with AIDS.
In 1987, after the discovery of the first patient infected with AIDS, the existence of AIDS in Iran was officially made public.
The Contaminated Blood Case
The Contaminated Blood case was set in the time of former Prime Minister Laurent Fabius, in which blood contaminated with dangerous viruses was distributed in France. In addition, the Mario France Institute produced blood coagulation factors contaminated with HIV and hepatitis and exports them to some countries such as West Germany, Italy, Argentina, Saudi Arabia, Iraq, Iran, etc. This factor is used to help coagulate the blood of many hemophiliacs and hospitalized patients, and because of the negligence of the French Institute, a certain number of hemophiliac patients were infected with HIV or hepatitis C as a result of a blood transfusion in these countries.
It’s just that the contaminated blood was distributed by the administration of Fabius for 6 months, but its problems for consumers have persisted for years and remain until now. French hemophilia organizations of the time state that due to the negligence of the administration of Fabius, almost 8,000 people were infected with the AIDS virus in France. The situation was much worse for the hepatitis virus. Following this blood transfusion, 400,000 French people were infected with the virus, among the transfused patients 4,000 people were hemophiliacs. The situation of hemophilia patients who had to endure the pain and problems of two other dangerous diseases like AIDS or hepatitis was much worse than the others. Considering that importing countries were more likely to receive special purpose blood products; This problem has become much more serious for hemophiliacs in these countries and has caused many victims.
In general, The Contaminated Blood case, by the number and quality of the victims and the intensity of the institutional crisis, seized the French with dread and generated a serious and deep public health crisis from the end of the 1970s to 1985. Due to the lack of necessary research on the AIDS epidemic, the lack of adequate screening, and adequate precautionary measures to avoid contamination, a large number of hemophiliacs have been infected by blood transfusion with the AIDS virus and ‘hepatitis. Due to the lack of necessary research on the AIDS epidemic, the lack of adequate screening, and adequate precautionary measures to avoid contamination, a large number of hemophiliacs have been infected by blood transfusion with the AIDS virus and ‘hepatitis. The victims of this contaminated blood were the inhabitants of many countries, including Germany, Italy, Argentina, Portugal, Saudi Arabia, Iran, France, Canada, Ireland, Great -Britain, Iraq, Greece, etc. It is estimated that in Canada, about 33,000 people, in the United States, between 6,000 and 10,000 citizens, and in Iran, 193 Iranians were infected with hepatitis C and AIDS-contaminated blood.
At that time, it was hoped that thanks to concentrate technology hemophilia patients would be improved. During the 1970s and 1980s, blood concentrates were collected in countries where, in some cases, ordinary people were paid to donate blood. This caused many people to donate blood in order to receive money whose blood was not suitable for transfusion. In the case of France, there was no payment for blood donation, but it turned out that some drug addicts in Paris were donating blood for sandwiches and free coffee. The main problem was that in blood concentrates, if a donor was infected with a blood-borne disease (hepatitis before the 1980s), he could contaminate all concentrates from a mixed blood group.
On the other hand, the AIDS virus was unknown until the early 1980s, and there was no evidence that it could be transmitted through blood concentrate. After it was learned that AIDS could be transmitted through these samples of blood, no proper screening was done to control donor blood and there was no method to detect and diagnose infections transmitted through contaminated blood. Competition among manufacturing companies for faster and larger production is also cited as one of the negative reasons for this.
At that time (the 1980s), the Mario Institute in France delivered blood coagulation factors for use by hemophiliacs in addition to France to ten countries including Germany, Italy, Argentina, Saudi Arabia, Iraq, Iran, and Greece. Sometime later, France announced to the blood recipient countries that the blood carried the HIV/AIDS virus. Some countries returned the blood, some threw it away, but in some cases, like Iran, before the implementation of blood testing, the National Blood Transfusion Center of Iran injected the contaminated blood to patients. These products have been distributed to 976 hemophilia patients in Iran, and 193 of them were infected with AIDS.
In 1987, after the discovery of the first patient infected with AIDS, the existence of AIDS in Iran was officially made public. With the complaint of the outraged victims and their families, a case was opened in Iranian courts in 1997 in this regard. In May 2011, approximately 200 patients receiving these contaminated blood samples died.
With the complaint of the outraged victims and their families, a case was opened in Iranian courts in 1997 in this regard. In May 2011, approximately 200 patients receiving these contaminated blood samples died.